AI-generated summary
The authors ran a 20-week randomized split-face study in 24 patients with mild to moderate facial acne, comparing sequential 1,450-nm diode laser plus blue light with blue light alone. They report that inflammatory lesions fell by 62.3% on the combination side and 35.2% on the blue light side at 12 weeks, and that only the combination improved noninflammatory lesions and sebum output. Adverse effects were mild and resolved within a day.
- Participants
- 24
- Who or what was studied
- Patients with mild to moderate facial acne vulgaris
- Wavelengths
- 450 nm
- Limits stated in the abstract
- The abstract does not describe a sham or no-treatment control and reports only a single 24-patient split-face trial.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.